- Multinational Liver Societies Announce New “Fatty” Liver Disease ...🔍
- New MASLD Nomenclature🔍
- From NAFLD to MASLD🔍
- From NASH to MASH🔍
- New Liver Disease Nomenclature Announced🔍
- Introduction of new terminology for fatty liver diseases🔍
- Results from Phase II MASH trial announced at EASL 2024🔍
- Associations rename fatty liver disease to reduce stigma🔍
Multinational liver societies announce new
Multinational Liver Societies Announce New “Fatty” Liver Disease ...
Nonalcoholic fatty liver disease (NAFLD) will now be metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD encompasses ...
New MASLD Nomenclature - AASLD
AASLD and its members are proud to have been one of the leading multinational liver societies that developed and finalized the new nomenclature for liver ...
From NAFLD to MASLD: 2023 Brings New Liver Disease ... - HCPLive
Three years ago, a global committee dubbed the Nomenclature Development Initiative launched a process to consider whether the names for some ...
From NASH to MASH: New Terms for Liver Diseases Unveiled at the ...
Multinational liver societies announce new “fatty” liver disease nomenclature that is affirmative and non-stigmatizing(no date) org. AASLD ...
New Liver Disease Nomenclature Announced - ProSciento
Additional details about the new nomenclatures are available in the multinational liver societies' websites: La Asociación Latinoamericana ...
Introduction of new terminology for fatty liver diseases
The decision to change the terminology was made through a collaborative process involving global liver societies, patient advocacy organisations ...
Results from Phase II MASH trial announced at EASL 2024
Accessed June 2024. ... Multinational liver societies announce new “Fatty” liver disease nomenclature that is affirmative and non-stigmatizing.” ...
AASLD on X: "Read the latest! Hot off the press: Multinational Liver ...
Read the latest! Hot off the press: Multinational Liver Societies Announce New “Fatty” Liver Disease Nomenclature That Is Affirmative And Non-Stigmatizing ...
Associations rename fatty liver disease to reduce stigma - The BMJ
Three national liver associations have renamed fatty liver disease as steatotic liver disease to be more “affirmative” and less stigmatising to patients.
A multisociety Delphi consensus statement on new fatty liver ...
... international atherosclerosis society; and international association for the study of obesity. Circulation. 2009; 120:1640-1645. Crossref · Scopus (11545).
Q&A: Liver Disease Gets a New Name: Why NAFLD Is Now MASLD
A group of multinational liver societies, including the American Association for the Study of Liver Diseases (AASLD) recently announced a ...
A Transformative Shift In Liver Disease Terminology: NAFLD ...
Unveiling new terminology for "Fatty" liver diseases, multinational liver societies advocate for research, patient care in SLD and MASLD.
Non-Alcoholic Fatty Liver Disease: The Silent Epidemic and ...
*Note: In June 2023, several multinational liver societies announced new nomenclature, renaming nonalcoholic fatty liver disease (NAFLD) to metabolic ...
Novel Nomenclature of Metabolic Dysfunction-Associated Steatotic ...
Multinational Liver Societies. Announce New “Fatty” Liver Disease Nomenclature. That Is Affirmative and Non-Stigmatizing. June 24,. 2023.
Societies Change Term for Fatty Liver To Focus on Steatosis
After years of discussion and review, an international working group has announced recently that they will refer to fatty liver disease as ...
A new Korean nomenclature for steatotic liver disease - PMC
The end product of these efforts was presented on June 27, 2024, during The Liver Week 2024. At this event, the KASL announced its position statement on the new ...
A multisociety Delphi consensus statement on new fatty liver ...
1). Nominating societies were instructed to select individuals actively engaged in NAFLD research or clinical practice of patients with NAFLD. The consensus was ...
Understanding Liver Disease's New Names NASH is now MASH
... liver disease comprehensively. In 2020, multinational liver associations and patient advocacy groups convened a group to review naming and ...
Survodutide Phase II trial shows 83% of adults treated achieved ...
EASL. Multinational liver societies announce new “Fatty” liver disease nomenclature that is affirmative and non-stigmatizing. Available at: ...
Liver Congress News | Multinational liver societies announce new ...
June 25, 2023: "Multinational liver societies announce new “fatty” liver disease nomenclature that is affirmative and non-stigmatizing Presenter: Mary ...